SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Roger's 1998 Short Picks

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dale Baker who wrote (11159)7/8/1998 9:19:00 AM
From: Tom Hua  Read Replies (1) of 18691
 
Dale, MUSE ALERT -- VVUS jumped 50% yesterday on Paine Weber upgrade. MUSE sales is dropping fast (see press release yesterday) and excerpts below.

Regards,

Tom

''About 67,000 prescriptions were dispensed for Muse in April and May, generating sales of $7.5
million. And 39,000 Caverject prescriptions were dispensed during the same two months, with sales
of $4.8 million,'' she added.

Duckwitz said sales figures indicated Viagra had wrested business away from its rivals, noting Muse
sales of $4.6 million in April fell to $2.9 million in May. Likewise, Caverject sales of $2.8 million in
April slipped to $2 million in May.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext